Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Delta-like protein 1 homolog refers to DLL1 (Delta-like canonical Notch ligand 1) and DLK1 (Delta-like non-canonical Notch ligand 1). Both are members of the delta/serrate/jagged family involved in Notch signaling. DLL1 is a canonical ligand that activates Notch receptors, influencing development, neurogenesis, and immune function. DLK1 is a non-canonical ligand that modulates Notch signaling, inhibiting adipogenesis and regulating muscle development. They are implicated in various diseases, making them potential therapeutic targets but require careful consideration due to their developmental roles.
DLL1: Activates Notch receptors. DLK1: Modulates/inhibits Notch receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Delta-like Protein 1 Homolog.